PURPOSE: To determine the association between hormonal contraceptive (HC) use, and behavior-related and biological cardiovascular risk factors among teenage girls in Germany. METHODS: HC use was assessed among 2,285 girls aged 13-17 years who participated in the health survey for children and adolescents (German Health Interview and Examination Survey for Children and Adolescents, KiGGS), between years 2003 and 2006. Prevalence of HC use was determined according to sociodemographic variables, behavior-related health risks, and overweight status. We compared HC users and nonusers with respect to biological cardiovascular risk factors, including systolic and diastolic blood pressure, and serum concentrations of lipids, lipoproteins, high sensitivity C-reactive protein (hs-CRP), and homocysteine. RESULTS: HC users were more likely than nonusers to combine several behavior-related health risks, independent of sociodemographic factors. In particular, HC use was strongly associated with current smoking (odds ratio: 3.4, 95% confidence interval: 2.7-4.3). HC use and behavioral factors showed an additive effect on biological cardiovascular risk factors, explaining between 6% and 30% of the population variance. Relative contributions of HC use ranged from <1% for systolic and diastolic blood pressure to 12% for hs-CRP. CONCLUSIONS: HC use among 13-17-year-old girls in Germany is significantly correlated with a more unfavorable cardiovascular risk profile, which is partly explained by a clustering of behavioral risk factors among HC users. When prescribing HC to teenagers, physicians should systematically assess avoidable behavioral cardiovascular risk factors and provide counseling tailored to the risk profile of the individual patient.
PURPOSE: To determine the association between hormonal contraceptive (HC) use, and behavior-related and biological cardiovascular risk factors among teenage girls in Germany. METHODS: HC use was assessed among 2,285 girls aged 13-17 years who participated in the health survey for children and adolescents (German Health Interview and Examination Survey for Children and Adolescents, KiGGS), between years 2003 and 2006. Prevalence of HC use was determined according to sociodemographic variables, behavior-related health risks, and overweight status. We compared HC users and nonusers with respect to biological cardiovascular risk factors, including systolic and diastolic blood pressure, and serum concentrations of lipids, lipoproteins, high sensitivity C-reactive protein (hs-CRP), and homocysteine. RESULTS: HC users were more likely than nonusers to combine several behavior-related health risks, independent of sociodemographic factors. In particular, HC use was strongly associated with current smoking (odds ratio: 3.4, 95% confidence interval: 2.7-4.3). HC use and behavioral factors showed an additive effect on biological cardiovascular risk factors, explaining between 6% and 30% of the population variance. Relative contributions of HC use ranged from <1% for systolic and diastolic blood pressure to 12% for hs-CRP. CONCLUSIONS: HC use among 13-17-year-old girls in Germany is significantly correlated with a more unfavorable cardiovascular risk profile, which is partly explained by a clustering of behavioral risk factors among HC users. When prescribing HC to teenagers, physicians should systematically assess avoidable behavioral cardiovascular risk factors and provide counseling tailored to the risk profile of the individual patient.
Authors: Jennifer Cheng; Kristen A Santiago; Zafir Abutalib; Kate E Temme; Ann Hulme; Marci A Goolsby; Carrie L Esopenko; Ellen K Casey Journal: PM R Date: 2020-12-19 Impact factor: 2.298
Authors: Elyse Olshen Kharbanda; Emily D Parker; Alan R Sinaiko; Matthew F Daley; Karen L Margolis; Mary Becker; Nancy E Sherwood; David J Magid; Patrick J O'Connor Journal: J Pediatr Date: 2014-09-01 Impact factor: 4.406
Authors: Martin Heier; Mark S Borja; Cathrine Brunborg; Ingebjørg Seljeflot; Hanna Dis Margeirsdottir; Kristian F Hanssen; Knut Dahl-Jørgensen; Michael N Oda Journal: Cardiovasc Diabetol Date: 2017-07-06 Impact factor: 9.951
Authors: Mohammed S Obsa; Getu Ataro; Nefsu Awoke; Bedru Jemal; Tamiru Tilahun; Nugusu Ayalew; Beshada Z Woldegeorgis; Gedion A Azeze; Yusuf Haji Journal: Front Cardiovasc Med Date: 2022-02-23